Shizuoka, Japan

Akira Iizuka

This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Nippon Light Metal Company, Ltd., Shizuoka Prefecture. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Iizuka. Retrieved from https://idiyas.com/inventor/akira-iizuka-ekkvpy72

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovator Akira Iizuka: Pioneering Patents in Display Technology and Cancer Treatment**

Introduction

Akira Iizuka, an accomplished inventor based in Shizuoka, Japan, has made significant contributions to the fields of flat panel display technology and biotechnology, amassing a total of five patents. His innovative approach and commitment to excellence have positioned him as a noteworthy figure in today's technological landscape.

Latest Patents

Among Iizuka's latest patents is a sophisticated pellicle frame body for flat panel displays. This invention aims to control external color effectively, thereby preventing the scattering of exposure light. Additionally, it facilitates the inspection for foreign object non-adhesion prior to use. The frame is designed as a stainless-steel member coated with a transparent oxide, with a film thickness ranging from 420 nm to 700 nm. A notable aspect of this patent is its provision for achieving a brightness index L* of 33 or less, enhancing the performance of flat panel displays.

His other significant patent involves the development of a new anti-B7-H4 antibody, characterized by high specificity and affinity. This monoclonal antibody targets an extracellular domain protein of human B7-H4 and is integral in creating a composition for cancer treatment. By binding the antibody to effector cells, Iizuka enhances the antibody-dependent cellular cytotoxicity, thereby improving therapeutic outcomes in cancer management.

Career Highlights

Over the years, Iizuka has lent his expertise to reputable organizations, including Nippon Light Metal Company, Ltd. and the Shizuoka Prefecture. His tenure at these companies reflects his dedication to advancing technology and innovation in various sectors.

Collaborations

Iizuka has collaborated with respected professionals in his field, including Koichi Nakano and Yoshihiro Taguchi. These partnerships have contributed to the successful development of his patents and innovations.

Conclusion

Akira Iizuka stands as a prominent inventor whose work continues to impact the fields of technology and medicine. His commitment to advancing innovative solutions reflects his dedication and expertise, making him a significant contributor in his area of specialization. Through his patents, Iizuka not only enhances technological capabilities but also strives to improve the lives of individuals battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…